Literature DB >> 28251684

Influence of age at diagnosis on the clinical characteristics of Crohn's disease in Korea: Results from the CONNECT study.

Sung Wook Hwang1,2, Jee Hyun Kim1, Jong Pil Im1, Byong Duk Ye2, Hoon Sup Koo3, Kyu Chan Huh3, Jae Hee Cheon4, You Sun Kim5, Young Ho Kim6, Dong Soo Han7, Won Ho Kim4, Joo Sung Kim1.   

Abstract

BACKGROUND AND AIM: The present study evaluated the clinical characteristics of Korean patients with Crohn's disease (CD) according to their age at diagnosis in a nationwide multicenter cohort study.
METHODS: A total of 1224 patients diagnosed with CD between 1982 and 2008 in 32 hospitals were included, and age at diagnosis was categorized as ≤ 16 (G1), 17-40 (G2), 41-59 (G3) and ≥ 60 (G4) years old. The baseline characteristics, medication, and intestinal resection were compared according to the age at diagnosis.
RESULTS: The number of patients in each age group was 155 (G1; 12.7%), 919 (G2; 75.1%), 120 (G3; 9.8%), and 30 (G4; 2.5%). The frequencies of ileocolonic disease in the late adult onset and elderly onset groups were lower than those in the other groups (P < 0.001). The cumulative probabilities of thiopurine and anti-tumor necrosis factor use in late adult onset and elderly onset groups were significantly reduced compared with those of the other groups (P < 0.01). However, the risk of the first intestinal resection was not different among the age groups. The ileal location (hazard ratio [HR]: 1.59; 95% confidence interval [CI]: 1.11-2.27), complicated behavior (HR: 3.35; 95% CI: 2.63-4.27), and early thiopurine use (HR: 0.27; 95% CI: 0.17-0.43) were associated with the first intestinal resection, whereas the age at diagnosis was not a risk factor.
CONCLUSIONS: Elderly onset CD may be related to favorable outcomes in Korea. Thus, the heterogeneity of this disease should be considered when developing a tailored strategy for the treatment of CD.
© 2017 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Crohn's disease; age at diagnosis; intestinal resection; medication

Mesh:

Substances:

Year:  2017        PMID: 28251684     DOI: 10.1111/jgh.13775

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  2 in total

Review 1.  Management of inflammatory bowel disease in older persons: evolving paradigms.

Authors:  Saurabh Kedia; Jimmy K Limdi; Vineet Ahuja
Journal:  Intest Res       Date:  2018-04-30

2.  Temporal trend of disease recognition, treatment paradigm, and clinical outcomes of Crohn disease in Thailand from 2000 through 2017: Is early use of thiopurines beneficial?

Authors:  Julajak Limsrivilai; Satimai Aniwan; Asawin Sudcharoen; Natapat Chaisidhivej; Piyaphan Prueksapanich; Nonthalee Pausawasdi; Phunchai Charatcharoenwitthaya; Supot Pongprasobchai; Sathaporn Manassatit
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.